| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 11/07/2007 | EP1851739A2 Xanthurenic acid derivative pharmaceutical compositoins and methods related thereto |
| 11/07/2007 | EP1850839A2 Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective rtk inhibitors |
| 11/07/2007 | CN101068573A Topical nepafenac formulations |
| 11/07/2007 | CN101066997A Human antibodies that bind human IL-12 and methods for producing |
| 11/07/2007 | CN101066447A Group b streptococcus proteins, and their use |
| 11/07/2007 | CN101066412A Brain nourishing and eyesight improving tea |
| 11/07/2007 | CN101066349A Chinese herbal medicine composition for treating dizziness |
| 11/07/2007 | CN101066347A Bagged Chinese herbal medicine prepn for preventing and treating ear block, ear pain and other ear diseases |
| 11/07/2007 | CN101066280A Eye drop of deep sea water |
| 11/07/2007 | CN101066275A Mangiferin-berberine composition |
| 11/07/2007 | CN100347169C 喹唑啉衍生物 Quinazoline derivatives |
| 11/07/2007 | CN100346789C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 11/07/2007 | CN100346781C Use of okadaic acid in preparation of medicine for resisting glaucoma operation scar |
| 11/06/2007 | US7291732 Isomeric fused pyrrolocarbazoles and isoindolones |
| 11/06/2007 | US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease |
| 11/06/2007 | US7291625 Administering a combination of nicotinic acid or nicotinamide and riboflavin to treat urticaria, asthma, allergic rhinitis, and allergic oculorhinitis |
| 11/06/2007 | US7291608 Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α |
| 11/06/2007 | US7291451 Modulation of pericyte proliferation |
| 11/06/2007 | US7291330 MD-1 inhibitors as immune suppressants |
| 11/06/2007 | CA2451519C Tablet comprising cetirizine and pseudoephedrine |
| 11/06/2007 | CA2353527C Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
| 11/01/2007 | WO2007122686A1 Benzimidazole compounds |
| 11/01/2007 | WO2007103765A3 Treatment with cyclosporin a |
| 11/01/2007 | WO2007082561A3 Method for the treatment of tinnitus |
| 11/01/2007 | WO2002090332A3 Novel aeylheteroalkylaminε derivatives |
| 11/01/2007 | US20070254963 Ozonidzed Pharmaceutical Composition and Method |
| 11/01/2007 | US20070254950 Oculoselective Drugs and Prodrugs |
| 11/01/2007 | US20070253959 Vascular endothelial cell growth factor antagonists |
| 11/01/2007 | US20070253933 Carotene Synthase Gene and Uses Therefor |
| 10/31/2007 | EP1849801A1 Tyrosine-based motif and clostridial neurotoxins |
| 10/31/2007 | EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 10/31/2007 | EP1848432A1 Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases |
| 10/31/2007 | EP1755584A4 Treatment of myopia |
| 10/31/2007 | EP1368301B1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 10/31/2007 | EP1289993B1 Caspase inhibitors and uses thereof |
| 10/31/2007 | EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 10/31/2007 | CN101063141A Moraxella(branhamella) catarrhalis antigens |
| 10/31/2007 | CN101062407A Function of erythropoietin in the preventing and treating of retinal injury |
| 10/31/2007 | CN101062404A Pidotimod injection and the producing method thereof |
| 10/31/2007 | CN101062313A Charles abraham decoction for treating trachoma |
| 10/31/2007 | CN101062246A Pill for improving kidney and eyes |
| 10/31/2007 | CN101062231A Pill of medlar and rehmannia |
| 10/31/2007 | CN101062230A Rehmannia bolus for improving eyesight |
| 10/31/2007 | CN101062179A Astragalus powder good for eyes |
| 10/31/2007 | CN101062150A Wattle-proof conjunctiva beverage |
| 10/31/2007 | CN101062116A Oral liquid good for eyes |
| 10/31/2007 | CN101062051A Injection liquid for vitreous cutting operation and the preparing method thereof |
| 10/31/2007 | CN101062009A Therapeutikum mit einem botulinum-neurotoxin |
| 10/31/2007 | CN100345834C 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 10/31/2007 | CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 10/31/2007 | CN100345827C Bicyclic aromatic compound |
| 10/31/2007 | CN100345594C Acetazolamide eye droplet and its application method in treating glaucoma |
| 10/31/2007 | CN100345550C Compound eye drops for treating electro-optic harmed eye |
| 10/31/2007 | CN100345540C Use of ampelopsin in preparing medicine for treating diseases related with aldose reductase |
| 10/31/2007 | CN100345528C Insert for the treatment of dry eye |
| 10/30/2007 | US7288650 Protein kinase inhibitors; anticarcinogenic agents; benign prostatic hyperplasia |
| 10/30/2007 | US7288571 Thyroid receptor ligands and method II |
| 10/30/2007 | US7288564 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders |
| 10/30/2007 | US7288519 Exocyclic peptide having amino acid sequence of a Fas surface domain; antagonists of the Fas receptor (Fas)-Fas ligand complex |
| 10/30/2007 | CA2276287C Screening method for compounds active in treating myopia and hypermetropia |
| 10/30/2007 | CA2231588C Process for the preparation of 4-(4-(4-(hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-.alpha.,.alpha.-dimethylphenylacetic acid and phosphorylated derivatives |
| 10/30/2007 | CA2164291C Methods and pharmaceutical compositions useful for treating neurological disorders |
| 10/25/2007 | WO2007121077A1 Brimonidine and timolol compositions |
| 10/25/2007 | WO2007120828A1 Use of il-i antibodies for treating ophthalmic disorders |
| 10/25/2007 | WO2007119623A1 Novel use of g-protein-conjugated receptor and ligand thereof |
| 10/25/2007 | WO2007119600A1 Carbazole compound |
| 10/25/2007 | WO2007119098A2 Use of an nmda receptor antagonist the treatment of tinnitus induced by cochlear excitotoxicity |
| 10/25/2007 | WO2007118276A1 Method of treatment of age-related macular degeneration(amd) |
| 10/25/2007 | WO2007097839A3 Ansamycin analogs or heat shock 90 inhibitors in combination with pdt treatin conditions of the eye |
| 10/25/2007 | US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes) |
| 10/25/2007 | US20070249719 Compounds for the treatment of metabolic disorders |
| 10/25/2007 | US20070249713 Prevention of Retinopathy by Inhibition of the Visual Cycle |
| 10/25/2007 | US20070249696 Compounds for the treatment of metabolic disorders |
| 10/25/2007 | US20070249695 Preventive and/or Therapeutic Agents for Meniere's Disease |
| 10/25/2007 | US20070249682 Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications |
| 10/25/2007 | US20070249659 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 10/25/2007 | US20070249598 selective antagonists of A2B adenosine receptors; for improving insulin sensitivity; asthma |
| 10/25/2007 | US20070249586 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 10/25/2007 | US20070249528 Histamine Binding Compounds for Treatment Method for Disease Conditions Mediated by Neutrophils |
| 10/25/2007 | US20070249010 Methods for treating glaucoma and macular degeneration |
| 10/25/2007 | US20070248697 Opthalmic solutions |
| 10/25/2007 | US20070248646 Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage |
| 10/25/2007 | US20070248645 Ophthalmic Oil-in-Water Type Emulsion with Stable Positive Zeta Potential |
| 10/25/2007 | US20070248644 Muller Stem Cells |
| 10/25/2007 | US20070248569 Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization |
| 10/25/2007 | CA2683756A1 Method of treatment of age-related macular degeneration(amd) |
| 10/25/2007 | CA2648932A1 Brimonidine and timolol compositions |
| 10/25/2007 | CA2648223A1 Use of il-i antibodies for treating ophthalmic disorders |
| 10/25/2007 | CA2617661A1 Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
| 10/24/2007 | EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 10/24/2007 | EP1846354A2 Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions |
| 10/24/2007 | EP1845984A2 Methylphenidate derivatives and uses of them |
| 10/24/2007 | EP1365771B1 Method of treating certain eye diseases |
| 10/24/2007 | EP1312366B1 Gelling aqueous pharmaceutical compositions |
| 10/24/2007 | EP1218348B1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 10/24/2007 | CN101057966A Liposome nanometer carrier situ gel preparation used for eye epidermal growth factor |
| 10/24/2007 | CN101057958A Traditional Chinese medicine compound for treating deaf |
| 10/24/2007 | CN101057869A Pearl eyesight instant gel for eye |
| 10/24/2007 | CN101057860A Eye drops and preparing method thereof |
| 10/24/2007 | CN101057696A Method for preparing pipewort eyesight beverage |